Worldwide Liquid Biopsy Market 2017-2021 by Analyte, Application - Screening/Drug Monitoring/Diagnostic and by Type of Cancer

Dublin, Oct. 11, 2017 -- The "The Worldwide Market for Liquid Biopsy (by Analyte [ctDNA, cfDNA, Other], by Application - Screening/Drug Monitoring/Diagnostic, by Region [US, Europe, Asia, ROW] and by Type of Cancer)" report has been added to Research and Markets' offering.

The term liquid biopsy encompasses various diagnostic methods that use liquid, non-tissue specimens to provide information that can aid in the diagnosis, treatment and monitoring of cancer. Currently, tissue biopsies, along with imaging techniques, are the standard methods used in the diagnosis of solid cancers, but despite their widespread use, they have many limitations that open the door for other diagnostic technologies in oncology clinical settings.

The Worldwide Market for Liquid Biopsy Contains Markets for the Following:

• Liquid Biopsy Technology Market Size and Forecast (CTC / ctDNA, cfDNA, EV and Other)
• Liquid Biopsy Application Market Size and Forecast (Screening, Therapy, Drug Monitoring)
• Liquid Biopsy Analyte Type Market Size and Forecast (Cancer, Infectious Disease, Other)
• Liquid Biopsy Geographic Market (US, EU, Asia, ROW)
• Top Ten Companies
• Market and Technology Overview
• Trends in the Market
• Profiles of Liquid Biopsy Competitors

Liquid Biopsy Testing Applications in Oncology include:

• Early diagnosis of cancer/ Screening
• Therapy personalization and monitoring - to help the physician select optimal therapies for individual patients and monitor their efficacy, as well as explore other options of treatment when the patient becomes resistant to current therapies
• Disease monitoring - to monitor residual disease, disease progression and tumor evolution, and detect recurrence earlier
• Prognosis of disease evolution
• Alternative method of testing when tissue samples are difficult/impossible to obtain, or when the primary site of metastatic disease is unknown.

The currently available liquid biopsy technologies employ the analysis of various types of analytes, including circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), extracellular vesicles, proteins, miRNA and mRNA. Among them, ctDNA and CTCs have been the most explored technologies for commercial applications up to the present time.

Key Topics Covered:

1: Executive Summary

• Introduction
• Liquid Biopsy Technologies
• Industry Structure
• Liquid Biopsy Market Revenues And Forecast

2: Liquid Biopsy Technologies

• Introduction
• Current Major Liquid Biopsy Technologies

3: Circulating Tumor Dna (Cfdna) Liquid Biopsy

• Introduction
• Advantages And Limitations Of Ctdna In Liquid Biopsy
• Current Ctdna-Based Liquid Biopsy Tests
  • Adaptive Biotechnologies
  • Biodesix
  • Epigenomics
  • Foundation Medicine
  • Genomic Health
  • Guardant Health
  • Myriad Genetics
  • Pathway Genomics
  • Personal Genome Diagnostics
  • QIAGEN
  • Roche Diagnostics
  • Sysmex-Inostics
  • Trovagene
  • Ctdna-Based Liquid Biopsy Tests In Development
  • Adaptive Biotechnologies
  • Biocartis
  • The Worldwide Market for Liquid Biopsy
  • ii July 2017 Kalorama Information
  • Epigenomics
  • Exact Sciences
  • Foundation Medicine
  • Genomic Health
  • GRAIL
  • Inivata
  • Natera
  • Trovagene

4: Circulating Tumor Cells (Ctcs) Liquid Biopsy

• Introduction
• Challenges In The Development Of Ctcs-Based Liquid Biopsy Tests
• CTCS-Based Liquid Biopsy Tests
  • Biocept
  • Cynvenio Biosystems
  • Epic Sciences
• Gilupi
  • Menarini-Silicon Biosystems
• Qiagen
• CTCS-Based Liquid Biopsy Tests In Development
  • Angle
  • Biocept
  • Epic Sciences
  • Janssen Diagnostics

5: Extracellular Vesicles And Other Liquid Biopsy

• Introduction
• Liquid Biopsy Tests Based On Extracellular Vesicles
  • Biodesix
  • Exosome Diagnostics
  • Gensignia
  • Hologic
  • MDxHealth
  • OncoCyte
  • QIAGEN
  • Vermillion
  • VolitionRx

6: Liquid Biopsy Industry Analysis

• Introduction
• Tiers Of Competition
• Competitive Factors
• Significant Market Trends

7: Liquid Biopsy Market Size And Forecast

• Market Snapshot
• Market Forecast

8: Market By Type Of Analyte

• Circulating Tumor Dna
  • Market Snapshot
  • Revenue Forecast
  • Global Liquid Biopsy Market by Type of Analyte ($ millions), 2015-2021
• Circulating Tumor Cells
  • Market Snapshot
  • Revenue Forecast
  • Global Liquid Biopsy Market by Type of Analyte ($ millions), 2015-2021
• Extracellular Vesicles/ Other Analytes
  • Market Snapshot
  • Revenue Forecast
  • Global Liquid Biopsy Market by Type of Analyte ($ millions), 2015-2021

9: Market By Type Of Application

• Therapy Guidance And Monitoring
  • Market Snapshot
  • Revenue Forecast
• Diagnosis/ Screening
  • Market Snapshot
  • Revenue Forecast
• Disease Prognosis
  • Market Snapshot
  • Revenue Forecast

10: Market By Type Of Cancer

• Breast Cancer
  • Market Snapshot
  • Revenue Forecast
• Colorectal Cancer
  • Market Snapshot
  • Revenue Forecast
• Lung Cancer
  • Market Snapshot
  • Revenue Forecast
• Ovarian Cancer
  • Market Snapshot
  • Revenue Forecast
• Prostate Cancer
  • Market Snapshot
  • Revenue Forecast
• Other Cancers
  • Market Snapshot
  • Revenue Forecast

11: Liquid Biopsy Company Profiles

• Top Ten Companies In The Liquid Biopsy Market
• Biocept, Inc.
• Epigenomics
• Foundation Medicine, Inc.
• Genomic Health
• Guardant Health, Inc.
• Menarini-Silicon Biosystems
• Myriad Genetics, Inc.
• Neogenomics
• Qiagen N.V.
• Roche Diagnostics
• Other Companies Activating In The Liquid Biopsy Market
• Adaptive Biotechnologies
• Angle, Plc
• Biocartis
• Biodesix
• Cynvenio Biosystems
• Epic Sciences
• Exact Sciences
• Exosome Diagnostics, Inc.
• Gensignia
• Gilupi Gmbh
• Grail
• Hologic, Inc.
• Inivata
• Mdxhealth
• Natera
• Oncocyte
• Pathway Genomics
• Personal Genome Diagnostics
• Resolution Biosciences
• Rosetta Genomics
• Sysmex-Inostics, Inc.
• Trovagene, Inc.
• Vermillion, Inc.
• Volitionrx

For more information about this report visit https://www.researchandmarkets.com/research/vp3cdh/the_worldwide

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Diagnostics, Drug Discovery, Oncology Drugs , In Vitro Diagnostics, Drug Abuse Screening